Table 2.

Repeated measures ANOVA for three subgroups, only including completers^a

	Control group (n = 125)			myCompass all users (N = 28)			myCompass active users (n = 9)
	Score	95% CI	p-value	Diff. from ctrl	95% CI	p-value	Diff from ctrl	95% CI	p-value
PHQ-9
Pre-treatment	10.36	[9.58, 11.15]	–	0.71	[−1.12, 2.54]	0.447	1.42	[−1.61, 4.45]	.359
Post-t change	−3.11	[−3.86, − 2.37]	.000*	0.11	[− 1.36, 1.86]	0.900	0.11	[−2.77, 2.99]	.939
19 week change	−3.51	[−4.26, − 2.77]	.000*	−0.02	[−1.77, 1.73]	0.979	−1.93	[−4.81, − 0.95]	.188
GAD-7
Pre-treatment	8.88	[8.24, 9.54]	–	0.08	[−1.45, 1.60]	0.922	−0.11	[−2.63, 2.41]	.932
Post-t change	−2.34	[−3.04, −1.65]	.000*	0.49	[−1.14, 2.11]	0.556	0.90	[−1.79, 3.58]	.511
19 week change	−2.36	[−3.06, −1.66]	.000*	1.00	[−0.62, 2.63]	0.226	0.58	[−2.10, −3.27]	.670

Note. PHQ-9 The Patient Health Questionnaire-9. GAD-7 The Generalized Anxiety Disorder 7-item scale

^aCompleters were defined as participants who completed all three surveys (at baseline and follow-ups)

^*indicates a significant result at the 0.05 level